|
Volumn 11, Issue 5, 2011, Pages 344-
|
Clinical impact of antimicrobial resistance: Design matters
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIINFECTIVE AGENT;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
BLOODSTREAM INFECTION;
ESCHERICHIA COLI INFECTION;
HUMAN;
INTENSIVE CARE UNIT;
LETTER;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION;
MORTALITY;
PNEUMONIA;
PRIORITY JOURNAL;
STAPHYLOCOCCUS INFECTION;
BACTEREMIA;
BACTERIAL INFECTION;
BACTERIUM;
CROSS INFECTION;
DRUG EFFECT;
METHODOLOGY;
MICROBIOLOGY;
NOTE;
RISK;
RISK FACTOR;
STANDARD;
TREATMENT OUTCOME;
FOLLOW UP;
ANTI-BACTERIAL AGENTS;
BACTEREMIA;
BACTERIA;
BACTERIAL INFECTIONS;
CROSS INFECTION;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
INTENSIVE CARE UNITS;
ODDS RATIO;
RESEARCH DESIGN;
RISK FACTORS;
TREATMENT OUTCOME;
|
EID: 79955442378
PISSN: 14733099
EISSN: None
Source Type: Journal
DOI: 10.1016/S1473-3099(11)70107-4 Document Type: Letter |
Times cited : (13)
|
References (4)
|